Infoway Clinical Innovation

1. Infoway Clinical Innovation

2. Clinical Innovation Program Framework • In May 2010 Infoway’s Board of Directors approved a Clinical Innovation strategy • The Clinical Innovation Program Framework • Is part of the “achieving clinical value” envelope • Builds on experience from earlier initiatives (PAQC, Innovation & Adoption) • Will generally invest in projects of smaller size and shorter duration than other Infoway projects • Replication/spread/shared learnings is key • Will have a strong benefits evaluation component that will demonstrate improvement in quality, access and/or productivity • Will result in benefits that can be easily communicated to the public and to our broader stakeholder community

3. Accelerate Projects • Accelerate Demonstration Projects will strategically invest in, and showcase, selected initiatives with tangible value for clinicians and Canadians. • Projects will test and develop future initiatives: • With benefits that can be easily communicated ot the public and our broader stakeholder community • That can be rapidly deployed • That can be rapidly adopted by consumers and/or providers • Focused on investment in areas where gaps currently existing Canada today

4. Project Focus Areas • Six investment themes have been identified • These focus areas were determined based on a number of inputs including a review of available literature, a readiness survey, Blueprint 2015, and broad stakeholder consultation (e.g. clinical reference groups, CIO Forum) • Six focus areas for investment in clinical innovation: • E-referral • CPOE (hospital) • CPOE (community) • Synoptic reporting • Decision support & workflow at point of care • Clinical messaging

5. Project Focus Areas

6. Project Funding • Projects will be considered on a first come, first served basis but with consideration to portfolio balance (e.g. geographic and focus areas) • Infoway will co-invest at up to 75% of eligible costs • Cash flow alleviation will allow for up to 20% of approved investment dollars to be flowed upon agreement signing.

7. Triage& screen based on investment criteria Overview of Project Approval Process External clinical value & technical reviews Portfolio balance assessment by Infoway staff Discussions with potential project sponsors to confirm business requirements and refine proposals based on feedback OMC Approval & Project Agreement

8. Mandatory Pre-requisite Criteria • Projects must have active users by October 2012 • The total Infoway investment will not exceed $1 million [not all projects will be of this size] • The Project Sponsor must have a confirmed funding source that will contribute at least 25% of eligible costs (and 100% of non-eligible costs) • Where applicable, the proposed projects must be supported by the relevant jurisdiction • Investments must fall within one of six program focus areas • Funded projects must be completed by October 2013 (except benefits evaluation, which may continue through to March 2014) • If the Sponsor has had a previous I&A or PAQC project, it must have successfully closed or be within 3 months of anticipated closure with a “low” risk rating • Infoway reserves the right to withdraw its support if sufficient progress has not been made within 3 months of project approval, e.g. agreement not finalized

9. Other investment considerations

10. Next Steps • If you are interested are in submitting a project proposal please contact your regional Infoway office or please direct any inquiries to innovation@infoway-inforoute.ca